Physician profile
Edward Barr
NPI 1619978723
$4,841.17
in general payments reported to CMS, 2019-2025
40 companies · $589 in 2025
The $589 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $568 · 2021: $1,016 · 2022: $792 · 2023: $605 · 2024: $570 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.61 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $662.20 | 2019-2025 | |
| Abbvie INC. | $566.12 | 2021-2025 | Vraylar, Creon, Linzess |
| Astrazeneca Pharmaceuticals Lp | $481.10 | 2019-2025 | Breztri, Farxiga |
| Lilly USA, LLC | $458.95 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $360.61 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.37 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $221.29 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Janssen Pharmaceuticals, INC | $214.59 | 2019-2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $199.69 | 2020-2022 | |
| Exact Sciences Corporation | $152.33 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $111.14 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Allergan, INC. | $84.10 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $82.41 | 2022-2024 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $69.82 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $68.50 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.